Here at diaTribe , we are constantly inspired by the huge number of organizations working to improve the lives of people with diabetes. On November 14, the IDF will host...

On June 16, FDA officials provided an update on its safety review of Takeda’s Actos (pioglitazone), announcing that going forward, prescribing information for Actos will...

(S)he said what?!?

While Lantus (Sanofi’s insulin glargine) is the current standard for basal insulins, companies are still investing significant efforts to develop even better long-acting...

Kelly reflects on her recent visit to Washington…

In late August, the European Commission approved Boehringer Ingelheim/Eli Lilly’s DPP-4 inhibitor, Tradjenta, for type 2 diabetes. Tradjenta (also known as Trajenta in...

The diaTribe team traveled to Amsterdam to attend the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD).

Recently, increasing evidence has suggested that weight-loss surgery (called “bariatric surgery”) can help improve type 2 diabetes management (or even cause its reversal...

During our recent trip to Portugal for the 47th Annual Meeting of EASD, we had the chance to see the once-weekly GLP-1 drug Bydureon for the first time since its...

With humor and detail, Gary Scheiner, a certified diabetes educator and author of one of our favorite books about diabetes, Think Like a Pancreas, gives us his...

Although most blood glucose meters are theoretically able to upload test results to a computer, the reality can be a frustrating, time-consuming process. Different...

Larry Soler and Dr. James Gavin discuss Partnership for a Healthier America's efforts to fight childhood obesity.

Valeritas’ V-Go Disposable Insulin Delivery Device. In late July, Valeritas announced it had received CE Mark approval for its V-Go disposable insulin delivery device,...

While the rest of America was watching the Super Bowl, we were taking in the countryside in Montpellier, France, at first annual European Diabetes Technology and...

Kerri Morrone Sparling advocates for unity in the diabetes community.

On January 27, the Food and Drug Administration (FDA) granted approval to Bydureon, a new drug for type 2 diabetes that is injected once a week. Approved last year in...

In welcome news, the pharmaceutical companies Amylin, Eli Lilly, and Alkermes announced in early July that Bydureon , a drug for people with type 2 diabetes meant to be...

The diaTribe team had an outstanding evening in San Francisco for World Diabetes Day on November 14, which included blue hula hooping in Union Square. (For those who...

World Diabetes Day 2007 - Beautiful Landmarks for an Unrecognized Epidemic (B.L.U.E)

In exciting news, Vivus announced that it intends to resubmit its weight-loss drug Qnexa to the FDA for review by the end of October. As a reminder, in October 2010, the...